Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Latzin, P
Right arrow Articles by Griese, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Latzin, P
Right arrow Articles by Griese, M
Thorax 2005;60:39-44
© 2005 BMJ Publishing Group Ltd & British Thoracic Society


PAEDIATRIC LUNG DISEASE

Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis

P Latzin1, M Tredano2, Y Wüst1, J de Blic3, T Nicolai1, B Bewig4, F Stanzel5, D Köhler6, M Bahuau2, M Griese1

1 Lung Research Group, Children’s Hospital of Ludwig Maximilians University, Munich, Germany
2 Laboratoire de Biochimie et Biologie Moléculaire, Hôpital d’Enfants Armand-Trousseau, AP-HP, Paris, France
3 Service de Pneumologie et Allergologie Pédiatriques, Hôpital des Enfants-Malades, Paris, France
4 Internal Medicine, University of Kiel, Germany
5 Internal Medicine, Asklepios Fachkliniken, Gauting, Germany
6 Internal Medicine, Grafschaft, Germany

Correspondence to:
Correspondence to:
Dr M Griese
Lung Research Group, Children’s Hospital of Ludwig Maximilians University, D-80337 Munich, Germany; matthias.griese{at}med.uni-muenchen.de

Background: Auto-antibodies against granulocyte-macrophage colony stimulating factor (GM-CSF) may be central to the pathogenesis of adult sporadic pulmonary alveolar proteinosis (PAP). The role of anti-GM-CSF auto-antibodies in paediatric forms of PAP is as yet unclear.

Methods: Anti-GM-CSF auto-antibodies were determined with the help of an antigen capture assay using serum and/or bronchoalveolar lavage (BAL) fluid from 27 patients with PAP (nine adults, 15 children, three neonates) and from 185 children with different diseases as disease controls (various pulmonary conditions and patients with malignancies).

Results: Anti-GM-CSF auto-antibodies were detected in the serum of five of seven adult PAP patients. They were not found in the serum of any of the children or neonates with PAP nor in any of the disease control patients. Raised anti-GM-CSF titres were found in BAL fluid from three of four adult patients with PAP. Anti-GM-CSF auto-antibodies were detected in BAL fluid of only one of the 15 children (age at diagnosis 11 years, age at BAL 24 years) and in none of the neonates with PAP, nor in any of the disease control patients.

Conclusions: The presence of anti-GM-CSF auto-antibodies seems to define an autoimmune disease underlying most of the adult sporadic type of PAP, but age at diagnosis may cause an overlap with children in some rare instances. In most of the children and all of the neonates the anti-GM-CSF titres were not significantly increased, indicating that alternative explanations are needed for the pathogenesis of the disease in these patients.


Abbreviations: ABCA3, human gene encoding ATP binding cassette transporter A3; BAL, bronchoalveolar lavage; CAP, congenital alveolar proteinosis; CD36, human gene encoding leucocyte differentiation antigen (scavenger receptor CD36); CF, cystic fibrosis; CSF2, human gene encoding colony stimulating factor 2 (GM-CSF); CSF2RA, human gene encoding GM-CSF receptor {alpha} subunit; CSF2RB, human gene encoding GM-CSF receptor ß subunit (common to interleukins 3 and 5); Csfgm, murine gene encoding GM-CSF; GM-CSF, granulocyte-macrophage colony stimulating factor; LPI, lysinuric protein intolerance; OLB, open lung biopsy; PAP, pulmonary alveolar proteinosis; PAS, Periodic acid Schiff; PPAR-{gamma}, human gene encoding peroxisome proliferator-activated receptor gamma; rh-GM-CSF, recombinant human GM-CSF; SFTPB, human gene encoding SP-B; SFTPC, human gene encoding SP-C; SP-B, surfactant associated protein B; SP-C, surfactant associated protein C; TBB, transbronchial biopsy

Keywords: children; pulmonary alveolar proteinosis; granulocyte-macrophage colony stimulating factor (GM-CSF); auto-antibodies




This article has been cited by other articles:


Home page
Eur Respir JHome page
M. Woischnik, A. Bauer, R. Aboutaam, A. Pamir, F. Stanzel, J. de Blic, and M. Griese
Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis
Eur. Respir. J., June 1, 2008; 31(6): 1197 - 1204.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
F-C Lin, G-D Chang, M-S Chern, Y-C Chen, and S-C Chang
Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis
Thorax, June 1, 2006; 61(6): 528 - 534.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society